Literature DB >> 3678733

Serum bilirubin fractionation using multilayer film method in hepatobiliary diseases in comparison with high performance liquid chromatography.

Y Adachi1, H Inufusa, M Yamashita, K Ozaki, A Kanbe, T Nanno, Y Ohba, H Nakamura, T Yamamoto.   

Abstract

The Ektachem multilayer film method (Ektachem) and high performance liquid chromatography (HPLC) were employed to fractionate and evaluate serum bilirubin species in 45 serum samples. The false-positive or false-high levels of bilirubin close-bonded with albumin (i.e. the delta bilirubin fraction (B delta] was obtained by Ektachem in sera of cases with normal bilirubin concentration and cases with unconjugated hyperbilirubinemia when compared with the results of HPLC. In the sera of cases with conjugated hyperbilirubinemia, Ektachem gave comparable levels of total bilirubin (TB), and unconjugated bilirubin (Bu) to those of HPLC, but underestimated conjugated bilirubin (Bc) and slightly overestimated B delta. To investigate the clinical significance of B delta in 113 cases of various hepatobiliary diseases with conjugated hyperbilirubinemia, the ratios of B delta to TB (B delta/TB) and to directly-reacting bilirubin fractions (B delta/(Bc + B delta] and that of Bc to B delta (Bc/B delta) were calculated based on the results of Ektachem and compared with each other during the course of jaundice. The mean B delta/TB was below 40% in various hepatobiliary diseases but became as high as approximately 60% in the convalescence stage. The mean B delta/(Bc + B delta) was below 50% in acute hepatitis (the serum bilirubin-elevating stage) and obstructive jaundice, and it increased to above 80% in the recovery stage. In decompensated liver cirrhosis and intrahepatic cholestasis the mean B delta/(Bc + B delta) was about 60%, indicating continuous backflow of Bc from liver cells. The changes in B delta/(Bc + B delta) were much greater than in B delta/TB.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678733     DOI: 10.1007/bf02776725

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  7 in total

1.  Estimation of unconjugated, conjugated, and "delta" bilirubin fractions in serum by use of two coated thin films.

Authors:  M W Sundberg; J J Lauff; J S Weiss; G M Dappen; T W Wu; R W Spayd; D Seligson
Journal:  Clin Chem       Date:  1984-08       Impact factor: 8.327

2.  The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia.

Authors:  J S Weiss; A Gautam; J J Lauff; M W Sundberg; P Jatlow; J L Boyer; D Seligson
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

3.  The measurement of fractionated bilirubin by Ektachem film slides. Method validation and comparison of conjugated bilirubin measurements with direct bilirubin in obstructive and hepatocellular jaundice.

Authors:  N P Kubasik; T K Mayer; A G Bhaskar; H E Sine; J P D'Souza
Journal:  Am J Clin Pathol       Date:  1985-10       Impact factor: 2.493

4.  Separation and quantitative estimation of four bilirubin fractions from serum and of three bilirubin fractions from bile.

Authors:  C C Kuenzle; M Sommerhalder; J R Rüttner; C Maier
Journal:  J Lab Clin Med       Date:  1966-02

5.  Separation of bilirubin species in serum and bile by high-performance reversed-phase liquid chromatography.

Authors:  J J Lauff; M E Kasper; R T Ambrose
Journal:  J Chromatogr       Date:  1981-12-11

6.  The Ektachem clinical chemistry slide for simultaneous determination of unconjugated and sugar-conjugated bilirubin.

Authors:  T W Wu; G M Dappen; R W Spayd; M W Sundberg; D M Powers
Journal:  Clin Chem       Date:  1984-08       Impact factor: 8.327

7.  Conjugated bilirubin: a better indicator of impaired hepatobiliary excretion than direct bilirubin.

Authors:  D Arvan; T L Shirey
Journal:  Ann Clin Lab Sci       Date:  1985 May-Jun       Impact factor: 1.256

  7 in total
  3 in total

1.  Novel assay for measuring serum conjugated bilirubin and its clinical relevance.

Authors:  Y Morimoto; T Ishihara; M Takayama; M Kaito; Y Adachi
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Type II crigler-Najjar syndrome with intrahepatic cholestasis.

Authors:  A Kagita; Y Adachi; A Kambe; T Kamisako; T Yamamoto
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

3.  Human serum bilirubin fractionation in various hepatobiliary diseases by the newly developed high performance liquid chromatography.

Authors:  Y Adachi; H Inufusa; M Yamashita; A Kambe; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.